Effect of CPP-ACP paste on dental caries in primary teeth: a randomized trial

J Dent Res. 2012 Sep;91(9):847-52. doi: 10.1177/0022034512454296. Epub 2012 Jul 17.

Abstract

This clinical trial tested the effect of daily application of 10% w/v calcium phosphopeptide-amorphous calcium phosphate (CPP-ACP) paste for 1 yr when added to regular toothbrushing with fluoridated toothpaste to prevent dental caries in pre-school children. High-caries-risk children aged 2½ to 3½ yrs in a suburban area of central Thailand were assigned to receive either CPP-ACP (n = 150) or a placebo control (n = 146) in addition to fluoridated toothpaste. The International Caries Detection and Assessment System (ICDAS) was recorded at baseline, 6 mos, and 1 yr. At 1 yr, a significant increase in mean numbers of enamel and dentin caries lesions, as well as dmfs, was found in both groups (p < 0.001). No significant difference was observed between groups on these 3 outcome measures (p = 0.23, 0.84, and 0.91, respectively). The odds of enamel caries lesion transitions to a state of regression or stability, compared with progression from baseline, was also not different between groups [OR = 1.00, 95% CI (0.86, 1.17)]. This trial found that daily application of 10% w/v CPP-ACP paste on school days for 1 yr, when added to regular toothbrushing with a fluoride toothpaste, had no significant added effect in preventing caries in the primary dentition of these pre-school children (ClinicalTrials.gov number CT01 604109).

Trial registration: ClinicalTrials.gov NCT01604109.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Cariostatic Agents / therapeutic use*
  • Caseins / therapeutic use*
  • Child, Preschool
  • DMF Index
  • Dental Caries / pathology
  • Dental Caries / prevention & control*
  • Dental Enamel / pathology
  • Double-Blind Method
  • Female
  • Fluorides / therapeutic use
  • Humans
  • Logistic Models
  • Male
  • Thailand
  • Tooth, Deciduous

Substances

  • Cariostatic Agents
  • Caseins
  • casein phosphopeptide-amorphous calcium phosphate nanocomplex
  • Fluorides

Associated data

  • ClinicalTrials.gov/NCT01604109